High risk injection drug use and uptake of HIV prevention and treatment services among people who inject drugs in KwaZulu-Natal, South Africa

被引：4
|
作者：
Zanoni, Brian [1 ,2 ,3 ]
Milford, Cecilia [4 ]
Sithole, Kedibone [4 ]
Mosery, Nzwakie [4 ]
Wilson, Michael [5 ,6 ]
Bosman, Shannon [7 ]
Smit, Jennifer [4 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Childrens Healthcare Atlanta, Atlanta, GA 30329 USA
[3] Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[4] Univ Witwatersrand, Fac Hlth Sci, Sch Obstet & Gynecol, MRU MatCH Res Unit, Durban, South Africa
[5] Adv Access & Delivery, Durban, South Africa
[6] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA
[7] Human Sci Res Council, Ctr Community Based Res, Pietermaritzburg, South Africa
来源：
PLOS ONE | 2023年 / 18卷 / 05期
关键词：
SUBSTANCE USE; BEHAVIORS; THERAPY; WHOONGA; DURBAN; ABUSE; CARE;
D O I：
10.1371/journal.pone.0281030
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
We conducted a mixed-methods study to understand current drug use practices and access to healthcare services for people who use injection drugs in KwaZulu-Natal, South Africa. We used respondent-driven sampling to recruit 45 people who used injection drugs within the past 6 months from KwaZulu-Natal, South Africa. We found high rates of practices that increase HIV/viral hepatitis risk including the use of shared needles (43%) and direct blood injections (bluetoothing) (18%). Despite 35% living with HIV, only 40% accessed antiretroviral therapy within the past year, and one accessed PrEP. None of the participants ever tested for Hepatitis C.
引用
收藏
页数：8
相关论文
共 49 条
  • [41] Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074
    Lancaster, Kathryn E.
    Mollan, Katie R.
    Hanscom, Brett S.
    Shook-Sa, Bonnie E.
    Ha, Tran, V
    Dumchev, Kostyantyn
    Djoerban, Zubairi
    Rose, Scott M.
    Latkin, Carl A.
    Metzger, David S.
    Go, Vivian F.
    Dvoriak, Sergii
    Reifeis, Sarah A.
    Piwowar-Manning, Estelle M.
    Richardson, Paul
    Hudgens, Michael G.
    Hamilton, Erica L.
    Eshleman, Susan H.
    Susami, Hepa
    Viet Anh Chu
    Djauzi, Samsuridjal
    Kiriazova, Tetiana
    Nhan, Do Thi
    Burns, David N.
    Miller, William C.
    Hoffman, Irving F.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
  • [42] Comparing PrEP initiation rates by service delivery models among high risk adolescent boys and young men in KwaZulu-Natal, South Africa: findings from a population-based prospective study
    Hlongwa, Mbuzeleni
    Basera, Wisdom
    Nicol, Edward
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [43] Contingency management and pre-exposure prophylaxis adherence support services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs
    Sung, Minhee L.
    Viera, Adam
    Esserman, Denise
    Tong, Guangyu
    Davidson, Daniel
    Aiudi, Sherry
    Bailey, Genie L.
    Buchanan, Ashley L.
    Buchelli, Marianne
    Jenkins, Mark
    John, Betsey
    Kolakowski, Jennifer
    Lame, Albana
    Murphy, Sean M.
    Porter, Elizabeth
    Simone, Laura
    Paris, Manuel
    Rash, Carla J.
    Edelman, E. Jennifer
    CONTEMPORARY CLINICAL TRIALS, 2023, 125
  • [44] Drug consumption rooms are effective to reduce at-risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study
    Lalanne, Laurence
    Roux, Perrine
    Donadille, Cecile
    Briand Madrid, Laelia
    Celerier, Isabelle
    Chauvin, Carole
    Hamelin, Naomi
    Kervran, Charlotte
    Maradan, Gwenaelle
    Auriacombe, Marc
    Jauffret-Roustide, Marie
    ADDICTION, 2024, 119 (01) : 180 - 199
  • [45] Outcomes of a pilot randomized clinical trial testing brief interventions to increase HIV pre-exposure prophylaxis uptake among rural people who inject drugs attending syringe services programs
    Surratt, Hilary L.
    Brown, Sarah
    Burton, Abby L.
    Cranford, Will
    Fanucchi, Laura C.
    Green, Christie
    Mersch, Stephanie M.
    Rains, Rebecca
    Westgate, Philip M.
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2025, 12
  • [46] Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative
    Milloy, M. -J.
    Wood, Evan
    Kerr, Thomas
    Hogg, Bob
    Guillemi, Silvia
    Harrigan, P. Richard
    Montaner, Julio
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (05) : 640 - 647
  • [47] Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose
    Nolen, Shayla
    Wilson, Taneisha
    Jacka, Brendan P.
    Li, Yu
    Beaudoin, Francesca L.
    Marshall, Brandon D. L.
    ADDICTIVE BEHAVIORS REPORTS, 2023, 17
  • [48] Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study
    Kiriazova, Tetiana
    Go, Vivian F.
    Hershow, Rebecca B.
    Hamilton, Erica L.
    Sarasvita, Riza
    Bui, Quynh
    Lancaster, Kathryn E.
    Dumchev, Kostyantyn
    Hoffman, Irving F.
    Miller, William C.
    Latkin, Carl A.
    HARM REDUCTION JOURNAL, 2020, 17 (01)
  • [49] High-Risk Behaviors Associated with Injection Drug Use Among Recently HIV-Infected Men Who Have Sex with Men in San Diego, CA
    Ghanem, Angie
    Little, Susan J.
    Drumright, Lydia
    Liu, Lin
    Morris, Sheldon
    Garfein, Richard S.
    AIDS AND BEHAVIOR, 2011, 15 (07) : 1561 - 1569
12345